Why the study?
Frequent avian influenza virus outbreaks in poultry lack effective vaccines and face antiviral resistance, making host-targeted mucosal cytokine therapies like ChIFN-λ3 a needed alternative.
Population
Chickens infected with avian influenza virus
Comparison
Mucosal administration of recombinant Lactococcus lactis secreting ChIFN-λ3 vs controls
Design
Preclinical animal study
Authors
Loading...
Hypothesis-generating for mucosal antivirals in poultry; leaves open translation to other species or settings.
Mucosal delivery of L. lactis secreting ChIFN-λ3 elicits a strong antiviral host defense against avian influenza virus infection in chickens, offering a potential alternative to conventional antivirals.
Bhowmick et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: